Andressa Lacerda is in mid-career stride, despite being only 26. She’s a founding partner and the CFO of Noble Inc., a company that will manufacture and distribute filtration systems to remove nanosilvers from wastewater. Also on the Noble Inc. agenda? The introduction of pharmaceuticals that will cure cancer and diseases caused by virus’. Her partner in this is Adam Noble, a science prodigy who has set both the Trent community and academic world on fire with research that he accomplished while still a high school student.
Andressa helped mentor Adam into becoming one of Canada’s “20 Under 20” in 2014. Together they have just signed on as cornerstone tenants of Trent University’s new Research and Innovation Park, with a $20 million, 50,000-square-foot production facility to be built soon.
Her own research has shed new light onto neurological disorders – in particular how mutations of LITAF protein cause the genetic Charcot-Marie-Tooth disease.
It’s a fascinating discussion – and one where another of Andressa’s talents shine: the ability to take complex ideas and make them relatable to students and laypeople.